Sidley Represents Capricor Therapeutics in Common Stock Offering
October 24, 2024
Related Professionals
Stay Up To Date
Sidley represented Capricor Therapeutics, Inc. in connection with an underwritten public offering of 5,073,800 shares of its common stock, including the exercise in full of the underwriters’ option to purchase additional shares to cover overallotments, bringing the total gross proceeds to Capricor from the offering to approximately US$86.3 million. Piper Sandler & Co. and Oppenheimer & Co. Inc. acted as the joint book-running managers for the offering.
The deal team was led by Rob Carlson and included Nick DeAngelis and Nithya Swaminathan.
This website uses cookies. Analytical cookies help us improve our website by providing insight on how visitors interact with our site, and necessary cookies which the website needs to function properly.
Necessary Cookies
The website cannot function properly without these necessary cookies, and they can only be disabled by changing your browser preferences. To learn more about these cookies, how we use them on our website, and how to revise your cookie settings, please view our cookie policy.
You have successfully set your edition to United States. Would you like to make this selection your default edition?
*Selecting a default edition will set a cookie.
This website uses cookies. Analytical cookies help us improve our website by providing insight on how visitors interact with our site, and necessary cookies which the website needs to function properly.
Necessary Cookies
The website cannot function properly without these necessary cookies, and they can only be disabled by changing your browser preferences. To learn more about these cookies, how we use them on our website, and how to revise your cookie settings, please view our cookie policy.